Skip to main content
Search hero banner

Search results

Showing 121 - 140 of 252 results

Doctors viewing a SPECT scan

Radionuclides in medicine

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs to diagnose or treat disease.

For three unknown medical radionuclides, students will graph their decay over time, use the graph to calculate their half-life, and determine the identify and use of each radionuclide using background information provided.

High Performance Macromolecular Crystallography Beamline (MX3)

High Performance Macromolecular Crystallography Beamline (MX3)

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Chronic Kidney disease of unknown origin

Chronic kidney disease of unknown origin

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

business-services-health-ansto

Nuclear Medicine

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

Imaging radiation

Gamma radiation imaging technology

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

Cryogenic Permanent Magnet Undulator (CPMU) source for the BRIGHT Nanoprobe beamline

Nanoprobe beamline (NANO) - under construction

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Pagination